enGene Therapeutics Inc.
ENGN • NASDAQ
enGene Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ronald H. W. Cooper, with a market cap of $487.0M.
Market Cap$487.0M
Employees33.0
CEORonald H. W. Cooper
CountryCanada
Healthcare
Biotechnology
Next EarningsJun 11, 2026 · in 2 monthsQ2 2026
Financials
enGene Therapeutics Inc. FAQ
Common questions about enGene Therapeutics Inc.
enGene Therapeutics Inc. is scheduled to report earnings for Q2 2026 on June 11, 2026.
enGene Therapeutics Inc. has approximately 33 employees.